Updates are available Correction dated 2019-02-05
Click to view Correction: https://doi.org/10.1007/s00296-018-4232-9
-
Authors
Bykerk, Vivian P. http://orcid.org/0000-0002-1219-3845
Burmester, Gerd R.
Combe, Bernard G.
Furst, Daniel E.
Huizinga, Tom W. J.
Ahmad, Harris A.
Emery, Paul
-
Funding
Funding for this research was provided by:
Bristol-Myers Squibb
- License Information
-
More Information
Article History
Received: 15 June 2018
Accepted: 5 October 2018
First Online: 20 October 2018
Change Date: 5 February 2019
Change Type: Correction
Change Date: 5 February 2019
Change Type: Correction
Change Details: The article ���On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis���, written by Vivian P.Bykerk, was originally published Online First without open access.
Change Details: The article ���On-drug and drug-free remission by baseline symptom duration: abatacept with methotrexate in patients with early rheumatoid arthritis���, written by Vivian P.Bykerk, was originally published Online First without open access.
Compliance with ethical standards
:
: The study was conducted in accordance with the Declaration of Helsinki and was approved by local institutional review boards or Independent Ethics Committees at each site (ClinicalTrials.gov; NCT01142726). The laws and regulatory requirements of all countries participating in this study were followed.
: All patients provided written informed consent.
